- Home
- ESLA vs OMH Comparison
ESLA vs OMH Comparison
Compare ESLA & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLA
- OMH
- Stock Information
- Founded
- ESLA 2021
- OMH 2015
- Country
- ESLA United States
- OMH Singapore
- Employees
- ESLA N/A
- OMH N/A
- Industry
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- OMH Real Estate
- Sector
- ESLA Health Care
- OMH Finance
- Exchange
- ESLA Nasdaq
- OMH Nasdaq
- Market Cap
- ESLA 35.5M
- OMH 35.8M
- IPO Year
- ESLA N/A
- OMH 2023
- Fundamental
- Price
- ESLA $0.98
- OMH $1.18
- Analyst Decision
- ESLA Strong Buy
- OMH Hold
- Analyst Count
- ESLA 1
- OMH 1
- Target Price
- ESLA $16.00
- OMH N/A
- AVG Volume (30 Days)
- ESLA 9.7K
- OMH 255.1K
- Earning Date
- ESLA 08-12-2025
- OMH 09-24-2025
- Dividend Yield
- ESLA N/A
- OMH N/A
- EPS Growth
- ESLA N/A
- OMH N/A
- EPS
- ESLA N/A
- OMH N/A
- Revenue
- ESLA N/A
- OMH $7,976,578.00
- Revenue This Year
- ESLA N/A
- OMH $28.40
- Revenue Next Year
- ESLA N/A
- OMH $23.07
- P/E Ratio
- ESLA N/A
- OMH N/A
- Revenue Growth
- ESLA N/A
- OMH 117.53
- 52 Week Low
- ESLA $0.63
- OMH $0.59
- 52 Week High
- ESLA $1.78
- OMH $5.46
- Technical
- Relative Strength Index (RSI)
- ESLA 62.41
- OMH 45.60
- Support Level
- ESLA $0.84
- OMH $1.07
- Resistance Level
- ESLA $0.99
- OMH $1.22
- Average True Range (ATR)
- ESLA 0.05
- OMH 0.09
- MACD
- ESLA 0.01
- OMH 0.02
- Stochastic Oscillator
- ESLA 97.44
- OMH 36.67
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.